Details for New Drug Application (NDA): 204373
✉ Email this page to a colleague
NDA 204373 describes DUTASTERIDE, which is a drug marketed by Acella, Actavis Labs Fl Inc, Adaptis, Amneal Pharms, Apotex, Ascent Pharms Inc, Aurobindo Pharma Ltd, Barr, Chartwell, Heritage Pharms Inc, Hikma, Humanwell Puracap, Norvium Bioscience, Nostrum Labs Inc, Rising, Strides Pharma, Vintage, Zydus Lifesciences, Aurobindo Pharma, Endo Operations, and Zydus Pharms, and is included in twenty-three NDAs. It is available from sixteen suppliers. Additional details are available on the DUTASTERIDE profile page.
The generic ingredient in DUTASTERIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
The generic ingredient in DUTASTERIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
Summary for 204373
| Tradename: | DUTASTERIDE |
| Applicant: | Zydus Lifesciences |
| Ingredient: | dutasteride |
| Patents: | 0 |
Pharmacology for NDA: 204373
| Mechanism of Action | 5-alpha Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 204373
Suppliers and Packaging for NDA: 204373
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DUTASTERIDE | dutasteride | CAPSULE;ORAL | 204373 | ANDA | Zydus Lifesciences Limited | 70771-1347 | 70771-1347-3 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (70771-1347-3) |
| DUTASTERIDE | dutasteride | CAPSULE;ORAL | 204373 | ANDA | Zydus Lifesciences Limited | 70771-1347 | 70771-1347-9 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (70771-1347-9) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Oct 4, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
